Sign in

You're signed outSign in or to get full access.

Julie Doyle

About Julie Doyle

Julie P. Doyle, 61, is an independent director of Bank of the James Financial Group, Inc. (BOTJ) serving since 2011; her current term (Group Two) expires in 2026 . She retired in 2021 as President and Executive Director of The Education & Research Foundation, Inc. (clinical research), and previously worked for Honeywell and Westinghouse . She holds a B.S. in Mechanical Engineering from the University of Notre Dame and an MBA from George Washington University . She currently serves as Board Chair of the University of Lynchburg and is the immediate past president of the Lynchburg City Schools Education Foundation .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Education & Research Foundation, Inc.President & Executive DirectorRetired 2021 Led a clinical research site; executive experience
HoneywellManagement roles (prior employment)Not disclosed Industrial/engineering background
WestinghouseManagement roles (prior employment)Not disclosed Industrial/engineering background

External Roles

OrganizationRoleTenure/StatusNotes
University of LynchburgBoard ChairCurrent as of 2025 Chair-Elect in 2024
Lynchburg City Schools Education FoundationImmediate Past PresidentCurrent as of 2025 Served as board President in 2024
Lynchburg City School BoardChair (former)Past Local education governance
Notre Dame Monogram ClubPresident (former)Past Alumni leadership
Centra Health, Inc.Director (former)Past Health system governance; interlock network with director Lewis C. Addison (former Centra CFO)

Board Governance

  • Independence: The board determined Julie P. Doyle is “independent” under Nasdaq Rule 5605(a)(2) .
  • Tenure and status: Director since 2011; Group Two; current term expires 2026 .
  • Committee memberships (Financial, year ended 2024): Audit Committee member; not listed on Executive, Nominating, or Compensation Committees .
  • Audit Committee oversight: Committee had 4 meetings in 2024; Lewis C. Addison is the audit committee financial expert; all committee members are independent .
  • Attendance: All directors attended the 2024 Annual Meeting; in 2023 Ms. Doyle did not attend the Annual Meeting (≥75% board/committee meeting attendance overall in 2023 for all directors) .
CommitteeMembershipChairNotes
Audit CommitteeMember Augustus A. Petticolas Jr. 4 meetings in 2024; oversees risk management
Executive CommitteeNot listed Thomas W. Pettyjohn Jr. 12 meetings in 2024
Nominating CommitteeNot listed Watt R. Foster, Jr. Independent members
Compensation CommitteeNot listed Thomas W. Pettyjohn Jr. Independent; Financial Committee did not meet in 2024 (Bank’s met)

Fixed Compensation

  • Structure (non-employee directors): Cash-only fees and retainers; no equity awards under the 2018 Equity Incentive Plan . Standard fees include board meeting fees and annual retainers (detail below); committee meetings $400 per meeting; if Financial & Bank committee meetings occur same day, $400 total .
  • 2023 standard schedule (illustrative): Board fees $1,000 per meeting ($1,200 when combined Financial/Bank); annual retainer $8,000 for directors; committee chair retainers ($3,000 Audit/Executive/Compliance; $2,000 Compensation/Nominating) .
YearFees Earned or Paid in Cash ($)Option Awards ($)Non-Equity Incentive ($)All Other ($)Total ($)
2024$24,200 - - - $24,200
2023$22,300 - - - $22,300
ComponentAmount
Board meeting fee (2023 schedule)$1,000 per meeting; $1,200 if Financial and Bank meetings same day
Annual director retainer (2023)$8,000
Committee meeting fee$400 per meeting; $400 total if Financial & Bank committees same day
Eligibility for equity awardsNon-employee directors not eligible under 2018 plan

Performance Compensation

  • Non-employee directors receive no performance-based equity or cash incentives; non-employee directors are not eligible for awards under the 2018 Equity Incentive Plan .
MetricApplies to Directors?Notes
RSUs/PSUs grant valueNo Non-employee directors ineligible
Options (strike/vesting)No Non-employee directors ineligible
Performance bonus tied to TSR/EBITDANo Cash fees/retainers only

Other Directorships & Interlocks

Company/OrganizationPublic/PrivateRolePotential Interlock/Notes
University of LynchburgPrivate (academic) Board Chair Academic governance
Lynchburg City Schools Education FoundationNon-profit Immediate Past President Local education philanthropy
Centra Health, Inc.Private (health system) Former director Network tie: Lewis C. Addison is former Centra CFO
Notre Dame Monogram ClubNon-profit (alumni) Former President Alumni leadership
Lynchburg City School BoardGovernmental Former Chair Public sector governance

No current public company directorships are disclosed for Ms. Doyle in BOTJ proxies .

Expertise & Qualifications

  • Mechanical engineering (B.S., University of Notre Dame) and MBA (George Washington University), bringing technical and financial acumen .
  • Executive leadership in clinical research operations and prior industrial experience at Honeywell/Westinghouse .
  • Community and academic governance experience (University of Lynchburg Board Chair; local education leadership) strengthening stakeholder ties .
  • Contributes “executive experience” and “strong financial background” per BOTJ board qualifications .

Equity Ownership

As-of DateCommon Stock Owned Beneficially (#)% of ClassNotes/Breakdown
March 26, 202418,203 <1% Includes 5,200 shares in husband’s revocable trust; 2,050 shares in husband-owned entity; 1,100 shares owned by husband
March 25, 202518,203 <1% Includes 5,200 shares in husband’s revocable trust; 2,050 shares in husband-owned entity; 1,100 shares owned by husband
  • Officers and directors as a group owned 696,798 shares (15.34%) as of March 26, 2024; 698,494 shares (15.37%) as of March 25, 2025 .
  • Anti-hedging policy prohibits directors and insiders from entering hedging transactions in BOTJ equity securities .
  • No disclosure of shares pledged as collateral for Ms. Doyle; no director-specific loans or related-party transactions involving Ms. Doyle are reported .

Governance Assessment

  • Board effectiveness: Ms. Doyle is an independent director (since 2011) and serves on the Audit Committee overseeing risk management; committee is fully independent with a designated financial expert (Addison) and met 4 times in 2024 .
  • Ownership alignment: She beneficially owns 18,203 shares (<1%), with family-related holdings disclosed; however, director compensation is cash-only and non-employee directors are ineligible for equity awards, potentially limiting ongoing pay-for-performance alignment .
  • Engagement: All directors attended the 2024 Annual Meeting; Ms. Doyle did not attend the 2023 Annual Meeting, though all directors met the ≥75% attendance threshold for board/committee meetings in 2023 .
  • Conflicts/related-party exposure: No related-party transactions disclosed for Ms. Doyle; broader board-related party items include rent paid to an entity owned by director Bryant and purchases of 2020 Notes by an unnamed board member/family; these did not affect director independence determinations for Ms. Doyle .
  • Compensation governance: Compensation Committees are independent; Financial’s committee did not meet in 2024 due to structure (employees at Bank level); Pearl Meyer engaged for executive benchmarking and incentive plan design at the Bank, with continued discretionary bonuses—a neutral-to-positive governance signal for executive pay process (not directly applicable to directors) .

RED FLAGS

  • Missed 2023 Annual Meeting attendance by Ms. Doyle (not pervasive; single-year) .
  • Cash-only director compensation without equity eligibility may weaken alignment, though personal share ownership partly offsets .
  • Network interlock: Prior Centra Health board service by Ms. Doyle and former Centra CFO service by director Addison—no transaction conflicts disclosed, but worth monitoring for potential influence channels .

Positive signals

  • Independence affirmed and active Audit Committee service focused on risk oversight .
  • Anti-hedging policy in place for directors and insiders .
  • Transparent disclosure of family-related beneficial ownership components .